FDA Clears Rapid Molecular Test for Group A Strep
The point-of-care assay provides results in 15 minutes and received a waiver for use in decentralized settings.
The point-of-care assay provides results in 15 minutes and received a waiver for use in decentralized settings.
The version 2.0 systems feature increased throughput, expanded assay flexibility, and the ability to run up to six unique assays per run.
The service applies CLSI M100 guidelines to PCR reports, delivering insights on pathogens and resistance markers to support labs and physicians.
Community Direct DX, Scienetix, and Advanta Genetics R&D combine with $30 million in funding to create a vertically integrated PCR testing platform.
Read MoreThe liquid biopsy test uses circulating tumor DNA to support therapy selection, trial matching, and monitoring—even when tissue is limited.
Read MoreBio-Rad Laboratories has expanded its ddPCR product portfolio with four new platforms, including the QX Continuum and QX700 series.
Read MoreNeoGenomics has launched PanTracer Tissue and PanTracer Tissue + HRD, advanced solid tumor profiling assays.
Read MoreAMDI has completed a successful clinical study of its Fast PCR-based Mini Respiratory Panel and earned MDSAP certification.
Read MoreThermo Fisher Scientific has launched the Applied Biosystems TrueMark PGx SNP + CNV Real-Time PCR Solution.
Read MoreTwo case studies illustrate how a newly developed sepsis test improves turnaround times and diagnostic accuracy.
Read MoreThe digital PCR system brings precise DNA and RNA quantification to diagnostics for applications like cancer monitoring and liquid biopsies.
Read MoreIndica Labs’ Lung Macrodissect AI, an AI-powered tool designed to enhance slide macrodissection and molecular pathology workflows.
Read MoreRoche launched new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions.
Read MoreEmpire Genomics Corp. has been awarded a national group purchasing agreement for Molecular Analyzers, Reagents with Premier, Inc.
Read MoreThere is a potential to use T-cell diagnostics to diagnose underlying post-viral syndromes by measuring the bodies adaptive immune resistance.
Read MoreThe new high-sensitivity troponin assay is designed for use on the the PATHFAST Biomarker Analyzer from Polymedco.
Read MoreThe QIAstat-Dx Analyzer 2.0 enables mobile access to test results, streamlining diagnostic processes and enhancing patient care.
Read MoreBIOTYPE presented a major upgrade to its benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures.
Read More